| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.003 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |